Ekso bionics reports record quarterly sales of $5.0 million in second quarter 2024

San rafael, calif., july 29, 2024 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company” or “ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended june 30, 2024.

EKSO Ratings Summary

EKSO Quant Ranking